TheraVet SA
ALVET | BR
Overview
Corporate Details
- ISIN(s):
- BE0974387194
- LEI:
- 984500804EBR3F1EFF71
- Country:
- Belgium
- Address:
- Avenue Jean Mermoz 32, 6041 Charleroi
- Website:
- https://www.thera.vet/en/home
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary. TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases. TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses. TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for TheraVet SA.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-07 19:57 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | |
| 2025-03-07 19:57 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | |
| 2025-01-27 00:00 |
Regulatory News Service
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
|
French | 644.6 KB | |
| 2024-12-12 18:00 |
Major Shareholding Notification
Informations privilégiées / Autres communiqués
|
French | 193.7 KB | |
| 2024-12-12 00:00 |
Major Shareholding Notification
CP_EGEIRO-121224_notification_de_transparence_ARTICLE 14.pdf
|
French | 193.7 KB | |
| 2024-12-05 18:00 |
Share Issue/Capital Change
Informations privilégiées / Autres communiqués
|
French | 182.9 KB | |
| 2024-11-18 18:00 |
Board/Management Information
Inside Information / Other news releases
|
English | 191.3 KB | |
| 2024-11-18 18:00 |
Board/Management Information
Informations privilégiées / Autres communiqués
|
French | 165.7 KB | |
| 2024-11-18 00:00 |
Board/Management Information
EGEIRO-181124_CP démission EB.pdf
|
French | 165.7 KB | |
| 2024-10-29 07:30 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 257.0 KB | |
| 2024-10-29 07:30 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 287.8 KB | |
| 2024-10-28 07:30 |
Post-Annual General Meeting Information
CP_TheraVet_AG_FR.pdf
|
French | 268.3 KB | |
| 2024-10-28 07:30 |
Declaration of Voting Results & Voting Rights Announcements
20241028_TheraVet_DDV.pdf
|
French | 223.8 KB | |
| 2024-10-28 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 243.8 KB | |
| 2024-10-17 07:30 |
Pre-Annual General Meeting Information
TheraVet - AGE 2024 (28 OCT) - Procuration - Personnes Morales_Legal Entities.p…
|
French | 410.4 KB |
Automate Your Workflow. Get a real-time feed of all TheraVet SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for TheraVet SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-21 | Bastianelli Enrico | Board | Other | 200,000 | 380,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Financière de Tubize S.A. | Belgium | TUBAT | |
|
Fine Foods & Pharmaceuticals Ntm | Italy | FF | |
|
Flerie AB | Sweden | FLERIE | |
|
Friulchem | Italy | FCM | |
|
FRP ADVISORY GROUP PLC | United Kingdom | FRP | |
|
Fuji Pharma Co.,Ltd. | Japan | 4554 | |
|
FunPep Company Limited | Japan | 4881 | |
|
Fuso Pharmaceutical Industries,Ltd. | Japan | 4538 | |
|
Galderma Group AG | Switzerland | GALD | |
|
GlaxoSmithKline PLC | United Kingdom | GSK |